Change in Focus Needed for Progress in HIV-Vaccine Research

Article

It is not time to give up on HIV vaccines but to change the way we pursue them, states a Viewpoint published by The Lancet.

Robert Gallo, of the Institute of Human Virology in Maryland, outlines seven major scientific obstacles that are blocking the development of a successful HIV-preventive vaccine. These include challenges with vaccine design and the lack of a truly useful animal model for studying HIV infection. Despite these problems Gallo states that it is not time to give up on HIV vaccines. He argues that in order to progress there should be a shift in emphasis to rational approaches that are based on solid knowledge of HIV biology.

Gallo states, . . . it is not time to give up on HIV vaccines but to change the way we pursue them. HIV-preventive vaccine research should clearly ignore empirically driven approaches and rely exclusively on rational approaches that are based on solid knowledge of HIV biology. I suggest after years of wandering, we have only begun to travel this path. A shift in emphasis to solving key scientific problems that have plagued the field is necessary.

He describes promising models by which this change in focus for vaccine research can be realized and administered, including the Gates Foundations Grand Challenge for Global Health, a scientistdriven program to find practical solutions to major scientific roadblocks.

Source: The Lancet

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content